EU signs contract with Moderna to obtain 300 million additional doses


The European Union has approved an agreement for the acquisition of 300 million additional doses of the Moderna vaccine against Covid-19, following a first contract for 160 million doses, announced on Wednesday the president of the Ursula von der Leyen Commission.

The agreement covers the purchase of 150 million doses, intended for delivery in the 3rd and 4th quarters of 2021, with an option of 150 million additional doses for delivery in 2022, the company said.

Brussels has been strongly criticized for delays in vaccine production which slowed down vaccination campaigns in member states.

With this new order, the EU should have 310 million doses of the Moderna vaccine this year, which on January 8 was the second to be approved by the European regulator, after that of the German-American duo BioNTech / Pfizer. Both use messenger RNA technology.

Seven million Europeans fully vaccinated

A total of 33 million doses of BioNTech-Pfizer, Moderna and AstraZeneca vaccines have been delivered to member states; and 22 million people in the EU have received at least one dose – of which seven million have received the two doses needed to be fully immunized – said von der Leyen.

The European Commission is responsible for negotiating vaccine pre-orders on behalf of the Twenty-Seven, and it is then up to states to finalize purchases directly from laboratories.


Source: Le Progrès : info et actu nationale et régionale – Rhône, Loire, Ain, Haute-Loire et Jura | Le Progrès by www.leprogres.fr.

*The article has been translated based on the content of Le Progrès : info et actu nationale et régionale – Rhône, Loire, Ain, Haute-Loire et Jura | Le Progrès by www.leprogres.fr. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!